NCT03793556View on ClinicalTrials.gov

Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

September 20, 2018

Study Completion Date

December 11, 2018

Conditions
Gastro-oesophageal Reflux Disease
Interventions
DEVICE

GERDOFF® + Omeprazole

GERDOFF® Hyaluronic acid + chondroitin sulphate + hydroxide aluminium Melt-in-mouth tablet 1100 mg + Omeprazole was orally administered once a day before breakfast (2 capsules). The treatment lasted 6 weeks (+/- 2 days).

DRUG

Omeprazole

Omeprazole, 2 capsules 20 mg, once a day before breakfast

Trial Locations (1)

20089

dr Alessandro Repici, Rozzano

All Listed Sponsors
lead

SOFAR S.p.A.

INDUSTRY

NCT03793556 - Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor | Biotech Hunter | Biotech Hunter